大型(≥20 mm)无蒂结肠息肉内镜下黏膜切除后切缘热消融对长期复发的影响
研究前瞻性纳入四个学术内镜中心接受内镜下黏膜切除(EMR)联合切缘热消融(MTA)的大型无蒂结肠息肉(LNPCP),评估第二次监测结肠镜(SC2)的复发情况,并与未行MTA的历史对照比较。结果显示MTA组SC2复发率显著低于对照组(1/472(0.2%)vs 9/260(3.5%);p<0.001)。作者认为若结肠已清除同步肿瘤,下次监测可潜在延长至3-5年。
要点
- MTA组SC2复发率0.2%(1/472),显著低于对照组3.5%(9/260),p<0.001。
- SC1无复发的LNPCP在后续监测至2年时不太可能复发。
- 若结肠已清除同步肿瘤,下次监测可潜在延长至3-5年。
核心结论
- 接受成功EMR联合MTA且在SC1无复发的LNPCP,在后续监测至2年时不太可能复发。
- 若结肠已清除同步肿瘤,下次监测可潜在延长至3-5年,从而降低成本并提高患者依从性。
研究设计与样本
- 前瞻性招募来自四个学术内镜中心接受EMR和MTA的LNPCP。
- SC1评估EMR瘢痕,无复发者在随后12个月进行SC2结肠镜。
- 历史对照臂来自2012年1月至2016年5月接受EMR但未行MTA的LNPCP。
- 主要结局为SC1无复发的所有LNPCP在SC2时的复发。
主要发现
- 截至2022年10月,90个月内1152个LNPCP接受EMR并完成MTA。
- 854个LNPCP接受SC1,其中29/854(3.4%)显示复发。
- 472个SC1无复发的LNPCP接受SC2;260个完成SC2随访的LNPCP构成对照臂。
- SC2复发在MTA组显著少于对照组(1/472(0.2%)vs 9/260(3.5%);p<0.001)。
临床怎么用
- 作者认为,接受成功EMR联合MTA且在SC1无复发的LNPCP,若结肠已清除同步肿瘤,下次监测可潜在延长至3-5年。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The efficacy of colorectal endoscopic mucosal resection (EMR) is limited by recurrence and the necessity for conservative surveillance. Margin thermal ablation (MTA) after EMR has reduced the incidence of recurrence at the first surveillance colonoscopy at 6 months (SC1). Whether this effect is durable to second surveillance colonoscopy (SC2) is unknown. We evaluated long-term surveillance outcomes in a cohort of LNPCPs that have undergone MTA. METHODS: LNPCPs undergoing EMR and MTA from four academic endoscopy centres were prospectively recruited. EMR scars were evaluated at SC1 and in the absence of recurrence, SC2 colonoscopy was conducted in a further 12 months. A historical control arm was generated from LNPCPs that underwent EMR without MTA. The primary outcome was recurrence at SC2 in all LNPCPs with a recurrence-free scar at SC1. RESULTS: 1152 LNPCPs underwent EMR with complete MTA over 90 months until October 2022. 854 LNPCPs underwent SC1 with 29/854 (3.4%) LNPCPs demonstrating recurrence. 472 LNPCPs free of recurrence at SC1 underwent SC2. 260 LNPCPs with complete SC2 follow-up formed the control arm from January 2012 to May 2016. Recurrence at SC2 was significantly less in the MTA arm versus controls (1/472 (0.2%) vs 9/260 (3.5%); p<0.001)). CONCLUSION: LNPCPs that have undergone successful EMR with MTA and are free of recurrence at SC1 are unlikely to develop recurrence in subsequent surveillance out to 2 years. Provided the colon is cleared of synchronous neoplasia, the next surveillance can be potentially extended to 3-5 years. Such an approach would reduce costs and enhance patient compliance.
引用
- O'Sullivan T, Mandarino FV, Gauci JL, et al. Impact of margin thermal ablation after endoscopic mucosal resection of large (≥20 mm) non-pedunculated colonic polyps on long-term recurrence. Gut. 2024. PMID: 39349006. doi:10.1136/gutjnl-2024-332907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。